CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY) Stock Rated “Hold” by Sell-Side Analysts

CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY) has earned an average recommendation of “Hold” from the five analysts that are currently covering the firm, MarketBeat.com reports. Five analysts have rated the stock with a hold recommendation. The average 12-month target price among brokers that have covered the stock in the last year is $117.00.

A number of research analysts have recently weighed in on the company. Royal Bank Of Canada lowered CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 price objective for the company. in a research report on Thursday, July 16th. Canaccord Genuity Group downgraded CochLear from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 18th. Finally, Jefferies Financial Group downgraded CochLear from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, July 22nd.

CochLear Trading Up 0.9%

Shares of OTCMKTS CHEOY opened at $49.84 on Friday. CochLear has a 52-week low of $31.82 and a 52-week high of $98.29. The firm’s fifty day moving average is $48.05 and its two-hundred day moving average is $52.98.

About CochLear

Cochlear Limited is an Australian medical device company that develops, manufactures and supplies implantable hearing solutions for people with moderate to profound hearing loss. Its portfolio includes cochlear implants, bone conduction implants and related sound processors, accessories and connectivity products designed to help users hear in a range of environments.

The company also provides clinical support, rehabilitation resources, software, technical services and ongoing care for recipients, clinicians and hearing professionals.